Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Conference News AHA 2016

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Shelley Wood

November 28, 2016

News Conference News AHA 2016

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Shelley Wood

November 16, 2016

Presentation AHA 2016

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

Presenter: David M Kaye

November 15, 2016

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Industry News

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

June 27, 2016

News Industry News

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

May 12, 2016

News Daily News

Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients

L.A. McKeown

March 29, 2016

News Conference News TCT 2015

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

October 11, 2015

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Daily News

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

June 09, 2015

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

Advertisement

My Takeaways From AHA 2016: Too Late, Too Soon—Time Waits for No Trial

Interatrial Shunt Device Shows Sustained Improvement in Heart Failure Patients With Preserved EF

Transcatheter Intracardiac Shunt Device Provides Sustained Clinical Benefit at One Year in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: The REDUCE LAP Heart Failure Trial

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Stealth BioTherapeutics Initiates Two Phase 2 Trials Evaluating Elamipretide for the Treatment of Heart Failure

Corvia Medical Announces CE Mark Approval and Enrollment of First Patients in Randomized Clinical Study

Percutaneous Interatrial Shunts May Offer New Hope for Advanced Heart Failure Patients

V-Wave Device Offers Functional, Hemodynamic Gains for Patients With Systolic HF

Biotronik launches 2 new studies

Bivalirudin Plus GPI Cuts Bleeding, Mortality in Heart Failure Patients Undergoing PCI

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content